登录新浪财经APP 搜索【信披】查看更多考评等级 证券代码：688739 证券简称：成大生物 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述或者重大遗漏，并对其内容 的真实性、准确性和完整性依法承担法律责任。 重要内容提示 公司董事会、监事会及董事、监事、高级管理人员保证季度报告内容的真实、准确、完整，不存在虚假 记载、误导性陈述或重大遗漏，并承担个别和连带的法律责任。 公司负责人、主管会计工作负责人及会计机构负责人（会计主管人员）保证季度报告中财务信息的真 实、准确、完整。 第一季度财务报表是否经审计 □是 √否 一、 主要财务数据 (一) 主要会计数据和财务指标 单位：元 币种：人民币 (二) 非经常性损益项目和金额 √适用 □不适用 单位:元 币种:人民币 对公司将《公开发行证券的公司信息披露解释性公告第1号——非经常性损益》未列举的项目认定为非 经常性损益项目且金额重大的，以及将《公开发行证券的公司信息披露解释性公告第1号——非经常性 损益》中列举的非经常性损益项目界定为经常性损益的项目，应说明原因。 □适用 √不适用 (三) 主要会计数据、财务指标发生变动的情况、原因 □适用 √ ...

Financial Performance - The company's operating revenue for Q1 2025 was CNY 358,395,731.16, a decrease of 1.73% compared to CNY 364,709,258.37 in the same period last year[5] - Net profit attributable to shareholders was CNY 72,218,005.25, down 11.35% from CNY 81,463,701.09 year-on-year[5] - Total revenue for Q1 2025 was CNY 358,395,731.16, a decrease of 1.1% compared to CNY 364,709,258.37 in Q1 2024[19] - Net profit for Q1 2025 was CNY 72,218,005.25, down 11.3% from CNY 81,463,701.09 in Q1 2024[19] - Operating profit for Q1 2025 was ¥88,612,647.35, down 48.6% from ¥172,340,409.52 in Q1 2024[29] - Net profit for Q1 2025 was ¥80,196,541.41, a decline of 45.0% compared to ¥145,908,490.99 in Q1 2024[29] Cash Flow - The net cash flow from operating activities increased by 15.77% to CNY 38,495,548.95, compared to CNY 33,252,685.73 in the previous year[5] - Cash flow from operating activities for Q1 2025 is ¥38,495,548.95, an increase of 15.5% compared to ¥33,252,685.73 in Q1 2024[22] - The net cash flow from operating activities for Q1 2025 was ¥25,693,550.62, down 67.2% from ¥78,399,476.34 in Q1 2024[31] - The company reported a cash inflow from sales of goods and services of ¥306,402,043.44 in Q1 2025, down 13.4% from ¥353,763,410.47 in Q1 2024[22] - The net cash flow from investment activities is -¥573,711,775.49, a significant decrease from ¥27,185,195.69 in the previous period[23] - The company reported a net cash outflow from investing activities of ¥528,225,792.41 in Q1 2025, compared to a smaller outflow of ¥50,151,806.51 in Q1 2024[31] Assets and Liabilities - Total assets at the end of the reporting period were CNY 10,080,623,416.18, reflecting a slight increase of 0.29% from CNY 10,051,587,266.31 at the end of the previous year[6] - Total assets as of March 31, 2025, were CNY 10,080,623,416.18, slightly up from CNY 10,051,587,266.31 at the end of 2024[17] - Total liabilities decreased to CNY 445,937,459.82 from CNY 489,119,315.20, a reduction of 8.8%[17] - Total liabilities decreased to ¥328,712,007.83 from ¥364,821,816.98, indicating a reduction of 9.9%[27] - The company’s total equity increased to CNY 9,634,685,956.36 from CNY 9,562,467,951.11, reflecting a growth of 0.8%[17] - The total equity increased to ¥10,062,485,088.05 from ¥9,982,288,546.64, reflecting a growth of 0.8%[27] Research and Development - Research and development expenses totaled CNY 86,826,788.11, representing 24.23% of operating revenue, a decrease of 1.92 percentage points from 26.15%[6] - Research and development expenses for Q1 2025 were CNY 51,861,758.56, down 12.1% from CNY 58,997,464.13 in Q1 2024[19] - Research and development expenses increased significantly to ¥63,157,263.29 in Q1 2025, compared to ¥19,874,594.47 in Q1 2024, reflecting a growth of 217.5%[29] Shareholder Information - The company reported a total of 25,451 common shareholders at the end of the reporting period[9] - The controlling shareholder, Liaoning Chengda, holds 54.67% of the company's shares, with a change in control from a state-owned entity to a private management company[11] - The company has completed the legal procedures for a mandatory general offer to all shareholders due to the change in control[11] Earnings Per Share - The basic and diluted earnings per share were both CNY 0.18, a decrease of 10% from CNY 0.20 in the same period last year[5] - Basic and diluted earnings per share for the current period are both ¥0.18, down from ¥0.20 in the previous period, reflecting a 10% decline[20] Cash and Cash Equivalents - Cash and cash equivalents decreased to CNY 3,961,121,082.99 from CNY 4,496,464,173.92 as of December 31, 2024, a decline of 11.9%[15] - Cash and cash equivalents at the end of the period are ¥3,962,685,051.08, down from ¥4,587,507,490.87 in the previous year, indicating a decrease of 13.6%[23] - The beginning balance of cash and cash equivalents was 4,421,617,178.42, while the ending balance was 3,918,934,767.46[32] Accounting Standards - The company will first implement new accounting standards starting from 2025, which will affect the financial statements[32]

成大生物公告，2025年第一季度营收为3.58亿元，同比下降1.73%；净利润为7221.8万元，同比下降 11.35%。 ...

Group 1 - The State Council Information Office will hold a press conference on April 28 to discuss policies related to stabilizing employment and the economy, promoting high-quality development [1] - The National Development and Reform Commission, Ministry of Human Resources and Social Security, Ministry of Commerce, and the People's Bank of China will present relevant measures and answer questions [1] Group 2 - The China Council for the Promotion of International Trade will hold a press conference on April 28 to release the global trade friction index for February 2025 and other trade-related data [3] - The press conference will also cover the latest preparations for the third Chain Expo and new policies to support foreign trade [3] Group 3 - The China Meteorological Administration will hold a press conference on April 28 to discuss the national weather and climate characteristics for April, as well as predictions for May [4] Group 4 - The first "Beijing Xiangshan Forum" will take place from April 28 to 30, focusing on global security challenges and opportunities, with participation from over 200 defense officials and experts from more than 30 countries [5] Group 5 - On April 28, a total of 17 companies will have their restricted shares released, amounting to 1.727 billion shares with a total market value of 24.677 billion yuan [6] - Companies with the highest share unlock volumes include China Resources Materials, Chengda Bio, and Wangbian Electric [6] Group 6 - 19 companies announced stock repurchase progress on April 28, with 18 companies disclosing new repurchase plans [7] - The highest repurchase amounts were reported by Tianyuan Environmental Protection, Jinli Permanent Magnet, and Zhenhua Heavy Industry [7] Group 7 - A total of 176 billion yuan in 7-day reverse repos will mature today, with an operation rate of 1.5% [8]

智通财经APP获悉，4月28日共有27家上市公司的限售股解禁，解禁总市值约317亿元。 今日具体限售解禁股情况如下： | 股票简称 | 股票代码 | 限售股类型 | 解禁股数 | | --- | --- | --- | --- | | 时代新材 | 600458 | 股权激励限售流通 | 649.44万 | | 中航沈飞 | 600760 | 股权激励限售流通 | 361.77万 | | 中钢天源 | 002057 | 股权激励限售流通 | 424.38万 | | 万讯自控 | 300112 | 股权激励限售流通 | 171.15万 | | 新研股份 | 300159 | 股权激励限售流通 | 540万 | | 吉鑫科技 | 601218 | 股权激励限售流通 | 54.63万 | | 凯龙股份 | 002783 | 股权激励限售流通 | 9.74万 | | 东方精工 | 002611 | 股权激励限售流通 | 88万 | | 星帅尔 | 002860 | 股权激励限售流通 | 30.2万 | | 星光农机 | 603789 | 股权激励限售流通 | 513.57万 | | 口子窖 | 603589 | 股权 ...

// 一、市场要闻 // 1、国务院新闻办公室于4月27日（星期日）下午3时举行新闻发布会，请商务部副部长盛秋平和财政部、文化和旅游部、海关总署、税务总局、中国 民航局有关负责人介绍优化离境退税政策扩大入境消费有关情况，并答记者问。此外，27日还会公布中国3月规模以上工业企业利润数据。 2、全国31个省份的一季度经济运行情况已全部发布，其中21个省份达到或超过GDP预期增长目标，经济大省更是普遍超预期。从GDP排名来看，一 季度，上海、辽宁均连升2位，四川从第6位升至第5位；湖北则以6.3%增速领跑经济大省。此外，中西部和东北地区更敢花钱，消费增速排名前9名 均来自中西部和东北地区。 跨境贸易 国务院副总理何立峰出席跨境贸易便利化专项行动部署会并讲话。他指出，要抓好专项行动的组织实施，在取得阶段工作成效基础上，将成熟的举 措和经验做法尽快在全国复制推广。加力培育壮大外贸发展新动能，以更优口岸营商环境激发活力、应对外部冲击、稳定增长。 海关总署牵头部署开展跨境贸易便利化专项行动。专项行动为期5个月，将在全国25个城市开展，政策举措涵盖货物贸易、数字贸易、绿色贸易等领 域。 旅游 据交通运输部，2025年"五一" ...

据中国政府网消息，4月25日，国务院发布关于同意在海南全岛和秦皇岛等15个城市（地区）设立跨境电子商务综合试验区的批复（简称"批复"）。 从资金流向上来看，多股4月14日以来获得杠杆资金加仓，华贸物流、怡亚通、德邦股份融资净买入额分别为1.19亿元、0.89亿元、0.7亿元。 | | | 冷买入居前的跨境电商股 | | | | --- | --- | --- | --- | --- | | 代码 | 间称 | 4月14日以来 | 4月14日以来融资 | 总市值 | | | | 涨跌幅 (%) | 净买入 (亿元) | (亿元) | | 603128 | 华贸物流 | 8.50 | 1.19 | 86.92 | | 002183 | 怡加通 | 1.93 | 0.89 | 123.36 | | 603056 | 德邦股份 | -2.90 | 0.70 | 136.55 | | 301171 | 易点天下 | 17.51 | 0.68 | 126.70 | | 002537 | 避联会汇 | 35.91 | 0.58 | 105.31 | | 000417 | 合百集团 | -2.88 | 0.37 | 47.4 ...

Core Insights - Next week (April 28 - May 4), more A-share companies will face the unlocking of restricted shares, but the total market value of these unlockings will decrease compared to this week, with no single stock exceeding a market value of 10 billion yuan for unlocking [1][3] Summary by Category Unlocking Overview - A total of 54 stocks will face restricted share unlockings next week, with a combined unlocking quantity of 2.487 billion shares, amounting to a total market value of 42.354 billion yuan based on the closing price on April 25 [1][3] - On April 28 alone, 31 stocks will unlock shares with a combined market value of 27.780 billion yuan [1] Top Stocks by Unlocking Value - The stock with the highest unlocking market value next week is China Resources Materials (301090.SZ) at 6.176 billion yuan, followed by Chengda Bio (688739.SH) at 5.630 billion yuan [1][3] - Other notable stocks include Shenzhen Urban Transport (301091.SZ) with an unlocking market value of 4.097 billion yuan [3] Share Expansion - Five stocks will see their circulating shares increase by over 100%, with Rongmei Co. (301088.SZ) experiencing an increase of over 290% [1][9][12] - The stocks with the highest percentage of unlocking relative to total shares include China Resources Materials (57.47%), Rongmei Co. (57.13%), Chengda Bio (54.67%), and Zhongke Micro (688211.SH) (50.60%) [9][10] Company Performance - China Resources Materials reported a net profit of -569.6 million yuan for 2024, a year-on-year decline of 249.44%, with a basic earnings per share of -0.385 yuan [7] - As of April 25, the stock price of China Resources Materials was 6.99 yuan, reflecting a 1.64% increase since the beginning of the month, but a 29.62% decline compared to its issue price [7] - Chengda Bio's stock price was 24.79 yuan as of April 25, up 2.27% from the beginning of the month, but down 75.64% from its issue price [8]

星标 ★ IPO日报 精彩文章第一时间推送 下周（4月28日-5月4日），有更多A股企业迎来限售股解禁，但解禁总市值较本周将有所降低，且没有解禁市值超过百亿的股票。 东方财富Choice数据显示，下周A股市场将有54只股票面临限售股解禁，合计解禁数量为24.87亿股。按照4月25日收盘价计算，上述股票合计解禁市值为 423.54亿元。而仅在下周一（4月28日）就有31股票解禁，合计解禁市值为277.80亿元。 从解禁股情况来看，下周解禁市值最高的股票是华润材料（301090.SZ），4月28日解禁市值61.76亿元。排在第二位的是成大生物（688739.SH），4月28 日将解禁市值56.30亿元。 即将解禁的股票中，流通盘将增加超100%的有5只，其中，戎美股份（301088.SZ）的流通盘增加290%以上。 制图：佘诗婕 单股解禁市值百亿以下 从解禁市值情况来看，上述54只股票按最新收盘价计算，华润材料、成大生物、深城交（301091.SZ）解禁市值居前， 解禁市值分别为61.76亿元、56.30 亿元、40.97亿元，均为追加承诺限售股份上市流通。 | 序 | 代码 | 名称 | 解禁日期 | 本期解禁 ...

证券代码：688739 证券简称：成大生物 公告编号：2025 -029 辽宁成大生物股份有限公司 关于召开 2024 年度暨 2025 年第一季度 业绩说明会的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性依法承担法律责任。 辽宁成大生物股份有限公司（以下简称"公司"）于 2025 年 4 月 24 日发布公 司 2024 年年度报告，并将于 2025 年 4 月 30 日在上海证券交易所网站 （www.sse.com.cn）披露 2025 年第一季度报告，为便于广大投资者更全面深入 地了解公司 2024 年度和 2025 年第一季度经营成果、财务状况，公司计划于 2025 年 5 月 6 日上午 9:00-10:00 举行 2024 年度暨 2025 年第一季度业绩说明会，就 投资者关心的问题进行交流。 一、 业绩说明会类型 本次投资者说明会以网络互动形式召开，公司将针对 2024 年度和 2025 年第 一季度的经营成果及财务指标的具体情况与投资者进行互动交流和沟通，在信息 披露允许的范围内就投资者普遍关注的问题进行回答。 会议 ...